Your browser doesn't support javascript.
loading
MFD-GDrug: multimodal feature fusion-based deep learning for GPCR-drug interaction prediction.
Gu, Xingyue; Liu, Junkai; Yu, Yue; Xiao, Pengfeng; Ding, Yijie.
Affiliation
  • Gu X; State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
  • Liu J; School of Electronic and Information Engineering, Suzhou University of Science and Technology, Suzhou 215009, China.
  • Yu Y; School of Computer and Artificial Intelligence, Zhengzhou University, Zhengzhou 450001, China.
  • Xiao P; State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China. Electronic address: xiaopf@seu.edu.cn.
  • Ding Y; Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, Zhejiang 324003, China; Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu 611730, China. Electronic address: wuxi_dyj@163.com.
Methods ; 223: 75-82, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38286333
ABSTRACT
The accurate identification of drug-protein interactions (DPIs) is crucial in drug development, especially concerning G protein-coupled receptors (GPCRs), which are vital targets in drug discovery. However, experimental validation of GPCR-drug pairings is costly, prompting the need for accurate predictive methods. To address this, we propose MFD-GDrug, a multimodal deep learning model. Leveraging the ESM pretrained model, we extract protein features and employ a CNN for protein feature representation. For drugs, we integrated multimodal features of drug molecular structures, including three-dimensional features derived from Mol2vec and the topological information of drug graph structures extracted through Graph Convolutional Neural Networks (GCN). By combining structural characterizations and pretrained embeddings, our model effectively captures GPCR-drug interactions. Our tests on leading GPCR-drug interaction datasets show that MFD-GDrug outperforms other methods, demonstrating superior predictive accuracy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deep Learning Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Methods Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: China Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deep Learning Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Methods Journal subject: BIOQUIMICA Year: 2024 Document type: Article Affiliation country: China Country of publication: United States